GlobalData on MSN2mon
HMNC completes subject randomisation in Phase IIb MDD treatment trialHMNC Brain Health (HMNC) has completed the subject randomisation in its placebo-controlled Phase IIb OLIVE trial of a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback